Document is current
Any future updates will be listed below
-
Authors
Cantor, Erick Andrés https://orcid.org/0000-0002-0920-219X
Bejarano-Ramírez, Andrés Felipe https://orcid.org/0009-0008-5344-9246
Zambrano, Laura Chacón
Triana, Iván Camilo https://orcid.org/0000-0002-8349-5576
Vargas, Henry Alexander https://orcid.org/0000-0003-2039-1857
Segovia, Javier Mauricio https://orcid.org/0000-0001-8971-0911
Pino, Luis Eduardo https://orcid.org/0000-0003-4475-7470
Murillo, John Alejandro https://orcid.org/0000-0001-7450-8286
López, Roció https://orcid.org/0000-0001-7277-7482
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb
- License Information
-
More Information
Article History
Received: 12 April 2025
Accepted: 17 October 2025
First Online: 21 November 2025
Declarations
:
: The research was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and complied with all applicable institutional, national, and international guidelines and regulations for research involving human subjects. The study protocol was reviewed and approved by the Institutional Review Board (IRB) of the Hospital Universitario Fundación Santa Fe de Bogotá, under communication CCEI-15797-2023 dated October 24, 2023. The IRB determined that the study met the criteria for exemption from informed consent due to its retrospective and non-interventional design.
: The authors declare no competing interests.
